Advertisement

Topics

Stem Cell Companies in BioPortfolio's Corporate Database - Page: 43Twitter RSS

19:58 EDT 25th May 2017 | BioPortfolio

Stem Cell company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Stem Cell companies that have been added to our BioPortfolio's life-science corporate directory.

Search For More Stem Cell Companies

If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Stem Cell Companies.

More Information about Stem Cell on BioPortfolio

We have published hundreds of Stem Cell news stories on BioPortfolio along with dozens of Stem Cell Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Stem Cell for you to read.

Showing "stem embryonic progenitor cell" Companies 1051 to 1075 of 1,300+

Thursday 24th July 2014

Euroclone Limited (UK)

Euroclone Ltd. is a U.K. company distributing bio & biotechnology products throughout Europe. Cell biology, cytogenetics, immunology, molecular biology and instruments: Serving Science through Innovation is our credo. Euroclone's International Marketing operations are located in Switzerland while the European Distribution Center and warehouse are based in Italy.

Cell Therapeutics Limited (UK)

At CTI, we're taking a different approach to the treatment of cancer—one focused on developing, acquiring, and commercializing therapies to combat the disease without compromising patient quality of life. Our goal is safer, more effective cancer therapies that can make a meaningful difference to millions. Frequent conversations with medical professionals and their patients, financial analysts, m...

Celox Laboratories Incorporated

Celox Laboratories, Inc. is an internationally recognized biotechnology company and a leader in serum free cell culture and cryopreservation technologies.

Gendel Limited

Gendel is an innovative life sciences company formed in December 1998 to develop a drug delivery technology based on red cell sensitisation followed by the application of ultrasound. The company has made outstanding progress in the advancement of this platform technology.Exploiting the novel concepts and technology conceived by Professor Tony McHale at the University of Ulster, the Gendel localise...

BioMarin Pharmaceutical

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, focusing on product candidates that: * Address currently unmet medical needs * Suggest a clear-cut development profile * Provide an opportunity to be first-to-market The company's product portfolio is comprised of three approved products and multiple investigational product...

Axxima Pharmaceuticals AG

Axximaâ„¢ Pharmaceuticals AG (formerly VirGene) is the leader in the application of pathogen-host signal transduction intervention. The company develops proprietary drugs that are based on Axxima's revolutionary approach to generate a Signal Transduction Firewallâ„¢ (STFâ„¢) against pathogens. Axxima's business strategy is to pursue the highly desirable area of anti-infective drug disc...

Agscientific

We produce biochemicals and pharmaceutical raw materials. We aid researchers worldwide in the fields of Molecular Biology, Neurobiology, Cancer Research, Cell Biology, Drug Discovery, Agricultural Biotechnology, and Animal Health.

ALA Scientific Instruments Incorporated

We are a leading manufacturer of devices for focal drug application to cells and tissue, bath perfusion, and internal cellular perfusion for electrophysiology, cell biology, and neuroscience research.We also represent a variety of products in these f ields from well-known manufacturers such as HEKA (patch clamp amplifiers, data acquisition/analysis software) , NPI (single & two electrode voltage c...

AutoImmune Incorporated

AutoImmune Inc. is a biopharmaceutical company developing a new class of orally administered pharmaceutical productsfor the treatment of autoimmune and other cell-mediated inflammatory diseases and conditions. At the start of 1999 the Company was conducting clinical trials for the following products: Colloral(R), for the treatment of rheumatoid arthritis, and AI 502, for the treatment of chronic t...

DirectGene Incorporated

DirectGene was founded in 1999 to develop products in to treat unmet cancer conditions, primarily those of the breast, prostate, and pancreas.The company's technology is based on targeted delivery of genes to kill cancer cells, not repair them. The company accomplishes this by using genes that eliminate cancer cells through either toxicity or the selective replication of adenovirus in the cancer c...

Aastrom Biosciences Incorporated

Aastrom Biosciences, Inc. (Nasdaq: ASTM) is developing automated cell therapy systems designed to enable on-site cell production for therapeutic procedures using living cells in patients treated for cancer and other diseases and cells used in the restoration of normal tissues. The Company has received approval to affix the CE Mark to the various components of the AastromReplicell™ System, the SC...

Isolagen(TM), Inc.

Isolagen(TM), Inc. (Amex: ILE) is an aesthetic and therapeutic company committed to developing and commercializing scientific advances and innovative technologies. The company's technology platform includes the Isolagen Process(TM), a cell processing system for skin and tissue rejuvenation which is currently in clinical development for a broad range of aesthetic and therapeutic applications i...

Novagali Pharma

Novagali was founded in 2000 by Professor Simon Benita of the Hebrew University of Jerusalem, where its initial technology was invented. A first round of financing allowed the transfer of Novasorb™ technology from Israel to France and the development of proven applications.Novasorb™ drug delivery technology consists of a patented cationic submicron emulsion technology that improves the bioavai...

Filligent

In 2008, Filligent developed a revolutionary technology, called BioFriend(TM), which kills viruses and bacteria on contact. BioFriend's molecular technology can be applied to substrates such as rayon and cotton textile fiber. BioFriend(TM) captures pathogens by mimicking the sites on human cells to which they normally attach, then, destroys them by disrupting their surfaces (viruses) and cell ...

Alfacell Corporation

Alfacell Corporation is a biopharmaceutical company primarily engaged in the discovery and development of a new class of anti-cancer drugs from amphibian ribonucleases ("RNases"). RNases degrade ribonucleic acids ("RNA") causing an interruption in protein synthesis resulting in inhibition of cell growth and induction of apoptosis (programmed cell death). The Company's first produ...

InVitria

InVitria is a division of Ventria Bioscience, a privately held company committed to creating innovative products enabled by advancements in biotechnology. Ventria has developed a novel animal-free production system (ExpressTec) that is the foundation that has led to several breakthrough products. Ventria's human health products target gastrointestinal health and infectious disease. Ventria's Board...

AlphaMed Press

AlphaMed Press publishes the internationally renowned journals, "Stem Cells" and "The Oncologist." "Stem Cells," now in its 27th year, is the oldest and one of the world's top-tier peer-reviewed monthly journals in the fast-paced area of stem cells and regenerative medicine. "The Oncologist," in its 14th year, is a premier peer-reviewed monthly journal dedicated to physicians entrusted with the c...

CompuCyte Corporation

Located in Cambridge, Massachusetts, CompuCyte develops, manufactures, and markets advanced instrumentation for biological research and drug discovery. Our laser scanning technology and advanced software tools give investigators the power to unlock the secrets of the cell, and generate high-content data for the most demanding biological research.

Stemline Therapeutics, Inc.

Stemline Therapeutics, Inc. is a clinical stage biotechnology company developing novel oncology compounds directed to cancer stem cell targets. Stemline's lead compound, SL-401, targets the interleukin-3 receptor which is expressed on multiple hematological cancers including leukemia blasts and leukemia cancer stem cells. SL-401 has demonstrated single agent anti-tumor activity at tolerable doses ...

Avid Bioservices, Inc.

Avid Bioservices provides a comprehensive range of cGMP manufacturing services for the biotechnology and biopharmaceutical industries. Avid manufactures cGMP commercial product, as well as clinical supplies for all phases of clinical trials. The company's comprehensive range of cGMP services includes cell banking, stability testing, clinical and commercial product manufacturing and purification, ...

Esperance Pharmaceuticals, Inc.

Esperance Pharmaceuticals, Inc. is developing a new class of targeted anticancer drugs using its Cationic Lytic Peptide (CLYP(TM)) platform technology. These drug candidates, called targeted membrane-disrupting peptides (tMDPs) and antibody drug conjugates (ADCs), selectively kill cancer cells, including cells known to be resistant to chemotherapeutic drugs, without harming normal cells. Targeting...

Amnis Corporation

Headquartered in Seattle, Washington, Amnis Corporation has created the ImageStream® Cell Analysis System, a breakthrough technology for high speed imaging and analysis of cells in flow. The system is a next generation instrument that combines the power of microscopy and flow cytometry in a single platform to advance applications in drug discovery, basic biomedical research and diagnostics. The I...

NeoStem, Inc.

NeoStem, Inc. continues to develop and build on its core capabilities in cell therapy, capitalizing on the paradigm shift that we see occurring in medicine. In particular, we anticipate that cell therapy will have a significant role in the fight against chronic disease and in lessening the economic burden that these diseases pose to modern society. We are emerging as a technology and market lead...

Semafore Pharmaceuticals, Inc.

Founded in 2000, Semafore Pharmaceuticals is a clinical-stage biotechnology company dedicated to the discovery and development of novel small molecule signal transduction inhibitors targeting the phosphoinositide-3-kinase (PI3K) pathway for the treatment of cancer and other serious diseases. The PI3K signaling pathway is vital to several biological process...

IsoRay Inc.

IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., is the sole producer of the Cesium-131 brachytherapy seed, used to treat prostate and other cancers. The Cesium-131 seed offers a significantly shorter half-life than the two other isotopes commonly used for brachytherapy, which results in a substantially faster delivery of therapeutic radiation, ...


More From BioPortfolio on "Stem Cell Companies in BioPortfolio's Corporate Database - Page: 43"

Quick Search
Advertisement
 

Corporate Database Quicklinks